株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ハイスループットスクリーニング (HTS) の世界市場 (~2023年):セルベースアッセイ・ラボオンチップ・バイオインフォマティクス

High Throughput Screening Market by Technology (Cell-Based Assays, Lab on a Chip, Bioinformatics), Application (Target Identification, Primary Screening, Toxicology), Product (Reagent, Instruments, Software, Service), End User - Global Forecast to 2023

発行 MarketsandMarkets 商品コード 295095
出版日 ページ情報 英文 245 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
ハイスループットスクリーニング (HTS) の世界市場 (~2023年):セルベースアッセイ・ラボオンチップ・バイオインフォマティクス High Throughput Screening Market by Technology (Cell-Based Assays, Lab on a Chip, Bioinformatics), Application (Target Identification, Primary Screening, Toxicology), Product (Reagent, Instruments, Software, Service), End User - Global Forecast to 2023
出版日: 2018年04月24日 ページ情報: 英文 245 Pages
概要

世界のハイスループットスクリーニング (HTS) の市場は予測期間中7.8%のCAGR (年間複合成長率) で推移し、2018年の148億7000万米ドルから、2023年には216億9000万米ドルの規模に成長すると予測されています。医薬品・バイオテクノロジー企業による各種イニチアチブ、R&D投資の拡大、技術革新、政府による資金投入、ベンチャー投資などの要因が同市場の成長を推進しています。

当レポートでは、世界のハイスループットスクリーニング (HTS) の市場を調査し、市場および技術の定義と概要、市場成長への各種影響因子および市場機会の分析、産業および技術動向、製品&サービス・技術・用途・エンドユーザー・地域/主要国別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

FIGURE 9 THE HTS MARKET

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題

第6章 産業動向

  • イントロダクション
  • 技術動向
    • ラベルフリー技術
    • オートメーション&小型化
    • マイクロ流体
  • 創薬プロセスにおけるHTS

第7章 ハイスループットスクリーニング市場の分析・予測:製品・サービス別

  • イントロダクション
  • 試薬・アッセイキット
  • 機器
  • 消耗品・付属品
  • ソフトウェア
  • サービス

第8章 ハイスループットスクリーニング市場の分析・予測:技術別

  • イントロダクション
  • セルベースアッセイ
    • 2D細胞培養
    • 三次元細胞培養
      • スキャフォールド型
      • スキャフォールドフリー型
    • 灌流細胞培養
  • ラボオンチップ
  • ウルトラハイスループットスクリーニング
  • バイオインフォマティクス
  • ラベルフリー技術

第9章 ハイスループットスクリーニング市場の分析・予測:用途別

  • イントロダクション
  • 標的同定・バリデーション
  • 一次・二次スクリーニング
  • 毒性評価
  • その他

第10章 ハイスループットスクリーニング市場の分析・予測:エンドユーザー別

  • イントロダクション
  • 医薬品・バイオテクノロジー企業
  • 学術・政府機関
  • CRO
  • その他

第11章 ハイスループットスクリーニング市場の分析・予測:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スぺイン
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • その他
  • ラテンアメリカ
  • 中東・アフリカ

第12章 競合環境

  • イントロダクション
  • 市場リーダーシップ分析
  • 競合シナリオ
    • 製品投入・アップグレード
    • 提携・協力・合意
    • 拡張
    • 買収
    • その他

第13章 企業プロファイル

  • THERMO FISHER SCIENTIFIC INC.
  • AGILENT TECHNOLOGIES, INC.
  • DANAHER CORPORATION
  • PERKINELMER, INC.
  • TECAN GROUP
  • AXXAM S.P.A.
  • BIO-RAD LABORATORIES
  • MERCK GROUP
  • HAMILTON COMPANY
  • CORNING INCORPORATED
  • BIOTEK INSTRUMENTS
  • AURORA BIOMED

第14章 付録

図表

LIST OF TABLES

  • TABLE 1: INCREASE IN COMPANY R&D EXPENDITURE (2014-2016)
  • TABLE 2: IMPACT ANALYSIS: MARKET DRIVERS
  • TABLE 3: IMPACT ANALYSIS: MARKET RESTRAINTS
  • TABLE 4: IMPACT ANALYSIS: MARKET OPPORTUNITIES
  • TABLE 5: IMPACT ANALYSIS: MARKET CHALLENGES
  • TABLE 6: HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 7: HIGH-THROUGHPUT SCREENING REAGENTS & ASSAY KITS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 8: HIGH-THROUGHPUT SCREENING INSTRUMENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 9: HIGH-THROUGHPUT SCREENING CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 10: HIGH-THROUGHPUT SCREENING SOFTWARE MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 11: HIGH-THROUGHPUT SCREENING SERVICES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 12: HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 13: CELL-BASED ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 14: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 15: CELL-BASED ASSAYS MARKET FOR 2D CELL CULTURE, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 16: CELL-BASED ASSAYS MARKET FOR 3D CELL CULTURE, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 17: CELL-BASED ASSAYS MARKET FOR 3D CELL CULTURE, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 18: HIGH-THROUGHPUT SCREENING MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 19: HIGH-THROUGHPUT SCREENING MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 20: HIGH-THROUGHPUT SCREENING MARKET FOR HYDROGELS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 21: HIGH-THROUGHPUT SCREENING MARKET FOR HYDROGELS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 22: HIGH-THROUGHPUT SCREENING MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 23: HIGH-THROUGHPUT SCREENING MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 24: HIGH-THROUGHPUT SCREENING MARKET FOR MATRIGEL, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 25: HIGH-THROUGHPUT SCREENING MARKET FOR COLLAGEN, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 26: HIGH-THROUGHPUT SCREENING MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 27: HIGH-THROUGHPUT SCREENING MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 28: HIGH-THROUGHPUT SCREENING MARKET FOR INERT MATRIX/SOLID SCAFFOLDS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 29: HIGH-THROUGHPUT SCREENING MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 30: HIGH-THROUGHPUT SCREENING MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 31: HIGH-THROUGHPUT SCREENING MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 32: HIGH-THROUGHPUT SCREENING MARKET FOR MICROPLATES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 33: HIGH-THROUGHPUT SCREENING MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 34: HIGH-THROUGHPUT SCREENING MARKET FOR ULTRA-LOW BINDING PLATES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 35: HIGH-THROUGHPUT SCREENING MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 36: HIGH-THROUGHPUT SCREENING MARKET FOR PERFUSION CELL CULTURE, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 37: HIGH-THROUGHPUT SCREENING MARKET FOR LAB-ON-A-CHIP, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 38: ULTRA-HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 39: HIGH-THROUGHPUT SCREENING MARKET FOR BIOINFORMATICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 40: HIGH-THROUGHPUT SCREENING MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 41: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 42: HIGH-THROUGHPUT SCREENING MARKET FOR TARGET IDENTIFICATION AND VALIDATION, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 43: HIGH-THROUGHPUT SCREENING MARKET FOR PRIMARY AND SECONDARY SCREENING, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 44: HIGH-THROUGHPUT SCREENING MARKET FOR TOXICOLOGY ASSESSMENT, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 45: HIGH-THROUGHPUT SCREENING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 46: HIGH-THROUGHPUT SCREENING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 47: HIGH-THROUGHPUT SCREENING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 48: HIGH-THROUGHPUT SCREENING MARKET FOR ACADEMIC AND GOVERNMENT INSTITUTES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 49: HIGH-THROUGHPUT SCREENING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 50: HIGH-THROUGHPUT SCREENING MARKET FOR OTHER END USERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 51: HIGH-THROUGHPUT SCREENING MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 52: NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 53: NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 54: NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 55: NORTH AMERICA: 3D CELL CULTURE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 56: NORTH AMERICA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 57: NORTH AMERICA: HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 58: NORTH AMERICA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 59: NORTH AMERICA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 60: NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 61: NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 (USD MILLION)
  • TABLE 62: NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 63: NIH BUDGET FOR VARIOUS DISCIPLINES IN 2015 AND 2016
  • TABLE 64: US: HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 65: US: CELL-BASED ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 66: US: 3D CELL CULTURE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 67: US: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 68: US: HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 69: US: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 70: US: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 71: US: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 72: US: HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 (USD MILLION)
  • TABLE 73: US: HIGH-THROUGHPUT SCREENING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 74: CANADA: HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 75: CANADA: CELL-BASED ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 76: CANADA: 3D CELL CULTURE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 77: CANADA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 78: CANADA: HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 79: CANADA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 80: CANADA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 81: CANADA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 82: CANADA: HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 (USD MILLION)
  • TABLE 83: CANADA: HIGH-THROUGHPUT SCREENING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 84: EUROPE: PHARMACEUTICAL R&D EXPENDITURE, BY COUNTRY, 2015 (USD MILLION)
  • TABLE 85: EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 86: EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 87: EUROPE: CELL-BASED ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 88: EUROPE: 3D CELL CULTURE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 89: EUROPE: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 90: EUROPE: HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 91: EUROPE: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 92: EUROPE: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 93: EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 94: EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 (USD MILLION)
  • TABLE 95: EUROPE: HIGH-THROUGHPUT SCREENING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 96: GERMANY: HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 97: GERMANY: CELL-BASED ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 98: GERMANY: 3D CELL CULTURE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 99: GERMANY: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 100: GERMANY: HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 101: GERMANY: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 102: GERMANY: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 103: GERMANY: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 104: GERMANY: HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 (USD MILLION)
  • TABLE 105: GERMANY: HIGH-THROUGHPUT SCREENING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 106: UK: HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 107: UK: CELL-BASED ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 108: UK: 3D CELL CULTURE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 109: UK: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 110: UK: HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 111: UK: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 112: UK: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 113: UK: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 114: UK: HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 (USD MILLION)
  • TABLE 115: UK: HIGH-THROUGHPUT SCREENING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 116: FRANCE: HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 117: FRANCE: CELL-BASED ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 118: FRANCE: 3D CELL CULTURE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 119: FRANCE: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 120: FRANCE: HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 121: FRANCE: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 122: FRANCE: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 123: FRANCE: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 124: FRANCE: HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 (USD MILLION)
  • TABLE 125: FRANCE: HIGH-THROUGHPUT SCREENING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 126: ITALY: HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 127: ITALY: CELL-BASED ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 128: ITALY: 3D CELL CULTURE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 129: ITALY: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 130: ITALY: HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 131: ITALY: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 132: ITALY: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 133: ITALY: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 134: ITALY: HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 (USD MILLION)
  • TABLE 135: ITALY: HIGH-THROUGHPUT SCREENING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 136: SPAIN: HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 137: SPAIN: CELL-BASED ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 138: SPAIN: 3D CELL CULTURE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 139: SPAIN: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 140: SPAIN: HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 141: SPAIN: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 142: SPAIN: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 143: SPAIN: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 144: SPAIN: HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 (USD MILLION)
  • TABLE 145: SPAIN: HIGH-THROUGHPUT SCREENING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 146: ROE: HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 147: ROE: CELL-BASED ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 148: ROE: 3D CELL CULTURE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 149: ROE: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 150: ROE: HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 151: ROE: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 152: ROE: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 153: ROE: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 154: ROE: HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 (USD MILLION)
  • TABLE 155: ROE: HIGH-THROUGHPUT SCREENING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 156: APAC: HIGH-THROUGHPUT SCREENING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 157: APAC: HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 158: APAC: CELL-BASED ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 159: APAC: 3D CELL CULTURE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 160: APAC: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 161: APAC: HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 162: APAC: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 163: APAC: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 164: APAC: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 165: APAC: HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 (USD MILLION)
  • TABLE 166: APAC: HIGH-THROUGHPUT SCREENING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 167: JAPAN: HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 168: JAPAN: CELL-BASED ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 169: JAPAN: 3D CELL CULTURE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 170: JAPAN: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 171: JAPAN: HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 172: JAPAN: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 173: JAPAN: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 174: JAPAN: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 175: JAPAN: HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 (USD MILLION)
  • TABLE 176: JAPAN: HIGH-THROUGHPUT SCREENING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 177: CHINA: HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 178: CHINA: CELL-BASED ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 179: CHINA: 3D CELL CULTURE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 180: CHINA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 181: CHINA: HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 182: CHINA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 183: CHINA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 184: CHINA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 185: CHINA: HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 (USD MILLION)
  • TABLE 186: CHINA: HIGH-THROUGHPUT SCREENING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 187: INDIA: HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 188: INDIA: CELL-BASED ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 189: INDIA: 3D CELL CULTURE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 190: INDIA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 191: INDIA: HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 192: INDIA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 193: INDIA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 194: INDIA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 195: INDIA: HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 (USD MILLION)
  • TABLE 196: INDIA: HIGH-THROUGHPUT SCREENING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 197: ROAPAC: HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 198: ROAPAC: CELL-BASED ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 199: ROAPAC: 3D CELL CULTURE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 200: ROAPAC: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 201: ROAPAC: HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 202: ROAPAC: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 203: ROAPAC: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 204: ROAPAC: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 205: ROAPAC: HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 (USD MILLION)
  • TABLE 206: ROAPAC: HIGH-THROUGHPUT SCREENING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 207: LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 208: LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 209: LATIN AMERICA: 3D CELL CULTURE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 210: LATIN AMERICA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 211: LATIN AMERICA: HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 212: LATIN AMERICA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 213: LATIN AMERICA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 214: LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 215: LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 (USD MILLION)
  • TABLE 216: LATIN AMERICA: HIGH-THROUGHPUT SCREENING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 217: MIDDLE EAST AND AFRICA: HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 218: MIDDLE EAST AND AFRICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 219: MIDDLE EAST AND AFRICA: 3D CELL CULTURE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 220: MIDDLE EAST AND AFRICA: SCAFFOLD-BASED TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 221: MIDDLE EAST AND AFRICA: HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 222: MIDDLE EAST AND AFRICA: ANIMAL-DERIVED HYDROGELS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 223: MIDDLE EAST AND AFRICA: SCAFFOLD-FREE TECHNOLOGIES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 224: MIDDLE EAST AND AFRICA: HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 225: MIDDLE EAST AND AFRICA: HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT AND SERVICE, 2016-2023 (USD MILLION)
  • TABLE 226: MIDDLE EAST AND AFRICA: HIGH-THROUGHPUT SCREENING MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 227: HIGH-THROUGHPUT SCREENING MARKET: COMPANY RANKING (2017)
  • TABLE 228: GROWTH STRATEGY MATRIX (2014-2018)
  • TABLE 229: PRODUCT LAUNCHES AND UPGRADES, 2014-2018
  • TABLE 230: PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS, 2014-2018
  • TABLE 231: EXPANSIONS, 2014-2018
  • TABLE 232: ACQUISITIONS, 2014-2018
  • TABLE 233: OTHER DEVELOPMENTS, 2014-2018

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS
  • FIGURE 3: DATA TRIANGULATION METHODOLOGY
  • FIGURE 4: GLOBAL HTS MARKET, BY PRODUCT & SERVICES, 2018 VS. 2023 (USD MILLION)
  • FIGURE 5: GLOBAL HTS MARKET, BY TECHNOLOGY, 2018 VS. 2023 (USD MILLION)
  • FIGURE 6: GLOBAL HTS MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 7: GLOBAL HTS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
  • FIGURE 8: HTS MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 9: INCREASING R&D SPENDING, GROWING INITIATIVES BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES ARE DRIVING THE HTS MARKET
  • FIGURE 10: DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING IN THE FORECAST PERIOD
  • FIGURE 11: US ACCOUNTED FOR THE LARGEST SHARE OF THE HTS MARKET IN 2017
  • FIGURE 12: NORTH AMERICA TO DOMINATE THE HTS MARKET DURING FORECAST PERIOD
  • FIGURE 13: REAGENTS & ASSAY KITS SEGMENT WILL CONTINUE TO DOMINATE THE HTS MARKET BY 2023
  • FIGURE 14: HIGH-THROUGHPUT SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15: PHARMACEUTICAL R&D EXPENDITURE, BY REGION, 2000 VS. 2010 VS. 2015
  • FIGURE 16: DRUG DISCOVERY PROCESS
  • FIGURE 17: REAGENTS & ASSAY KITS TO DOMINATE THE HIGH-THROUGHPUT SCREENING PRODUCTS & SERVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY, 2018 VS. 2023 (USD MILLION)
  • FIGURE 19: TARGET IDENTIFICATION AND VALIDATION SEGMENT TO DOMINATE THE HTS APPLICATIONS MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES WILL DOMINATE THE HTS MARKET IN 2023
  • FIGURE 21: HIGH-THROUGHPUT SCREENING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 22: NORTH AMERICA: HIGH-THROUGHPUT SCREENING MARKET SNAPSHOT
  • FIGURE 23: ASIA PACIFIC: HIGH-THROUGHPUT SCREENING MARKET SNAPSHOT
  • FIGURE 24: KEY DEVELOPMENTS, 2014-2018
  • FIGURE 25: THERMO FISHER SCIENTIFIC : COMPANY SNAPSHOT
  • FIGURE 26: AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
  • FIGURE 27: DANAHER: COMPANY SNAPSHOT
  • FIGURE 28: PERKINELMER: COMPANY SNAPSHOT
  • FIGURE 29: TECAN: COMPANY SNAPSHOT
  • FIGURE 30: BIO-RAD: COMPANY SNAPSHOT
  • FIGURE 31: MERCK GROUP: COMPANY SNAPSHOT
  • FIGURE 32: CORNING: COMPANY SNAPSHOT
目次
Product Code: BT 2220

"The global high-throughput screening (HTS) market projected to grow at a CAGR of 7.8%."

The HTS market is expected to reach USD 21.69 billion by 2023 from an estimated USD 14.87 billion in 2018, at a CAGR of 7.8%. The initiatives undertaken by pharmaceutical and biotechnology companies, increasing R&D spending, technological developments in HTS, and the availability of government funding and venture capital investments are the factors driving the growth of the HTS market. However, the capital-intensive nature of HTS and complexities in the field of assay development are expected to limit the growth of this market during the forecast period.

"The software segment is expected to register the highest CAGR during the forecast period."

On the basis of product & service, the HTS market is segmented into reagents & assay kits, instruments, consumables & accessories, software, and services. The software segment is expected to register the highest CAGR during the forecast period. The increasing automation of high-throughput screening and the availability of robust data management software tools, which enable researchers to develop systemic and process-oriented approaches toward HTS techniques are some of the factors contributing to the growth of this segment.

"Contract research organizations are expected to grow at the fastest rate during the forecast period."

On the basis of end user, the HTS market is segmented into pharmaceutical and biotechnology companies, academic and government institutes, contract research organizations (CROs), and other end users (hospitals and food, agriculture & environmental industries). The contract research organizations segment is expected to register the highest CAGR during the forecast period owing to the increasing outsourcing of HTS services by many pharmaceutical & biotechnology companies.

"APAC is projected to witness the highest growth during the forecast period."

North America held the largest share of the global HTS market in 2017. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing R&D spending, growing trend of outsourcing drug discovery services, growing public-private partnerships, and increasing government funding in this region.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-31%, Tier 2-46% and Tier 3-23%
  • By Designation - C-level-42%, Director Level-26%, Others-32%
  • By Region - North America-35%, Europe-30%, Asia Pacific-21%, RoW-14%

The prominent players in the global HTS market are: Agilent (US), Danaher (US), Thermo Fisher Scientific (US), PerkinElmer (US), Tecan (Switzerland), Axxam (Italy), Merck Group (Germany), Bio-Rad (US), Hamilton (US), Corning (US), BioTek (US), and Aurora Biomed (Canada).

Research Coverage:

The report analyzes the various HTS products and their adoption pattern. It aims at estimating the market size and future growth potential of the global HTS market for different segments such as product & service, technology, application, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global HTS market
  • Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and product launches in the global HTS market
  • Market Development: Comprehensive information on the lucrative emerging regions by product & service, technology, application, end user, and region
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global HTS market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global HTS market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. SCOPE OF THE STUDY
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED IN THE REPORT
  • 1.4. CURRENCY
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. HIGH-THROUGHPUT SCREENING: MARKET OVERVIEW
  • 4.2. HTS MARKET: DEVELOPED VS DEVELOPING COUNTRIES (2018 VS 2023)
  • 4.3. GEOGRAPHIC SNAPSHOT: HTS MARKET (2017)
  • 4.4. GEOGRAPHIC MIX: HTS MARKET
  • 4.5. HTS MARKET, BY PRODUCT & SERVICES (2018 VS 2023)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. MARKET DRIVERS
      • 5.2.1.1. Growing adoption of open innovation models in pharmaceutical and biotechnology companies
      • 5.2.1.2. Government funding and venture capital investments
      • 5.2.1.3. Increasing R&D spending
      • 5.2.1.4. Technological advancements
    • 5.2.2. MARKET RESTRAINTS
      • 5.2.2.1. Capital-intensive nature of HTS
      • 5.2.2.2. Complexities in the field of assay development
    • 5.2.3. MARKET OPPORTUNITIES
      • 5.2.3.1. Emerging markets
      • 5.2.3.2. Growing research activities in toxicology and stem cells
    • 5.2.4. MARKET CHALLENGES
      • 5.2.4.1. Dearth of skilled operators

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. TECHNOLOGICAL TRENDS
    • 6.2.1. LABEL-FREE TECHNOLOGY
    • 6.2.2. AUTOMATION & MINIATURIZATION
    • 6.2.3. MICROFLUIDICS
  • 6.3. HTS IN DRUG DISCOVERY PROCESS

7. HIGH-THROUGHPUT SCREENING MARKET, BY PRODUCT & SERVICE

  • 7.1. INTRODUCTION
  • 7.2. REAGENTS & ASSAY KITS
  • 7.3. INSTRUMENTS
  • 7.4. CONSUMABLES & ACCESSORIES
  • 7.5. SOFTWARE
  • 7.6. SERVICES

8. HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY

  • 8.1. INTRODUCTION
  • 8.2. CELL-BASED ASSAYS
    • 8.2.1. 2D CELL CULTURE
    • 8.2.2. 3D CELL CULTURE
      • 8.2.2.1. Scaffold-based technology
        • 8.2.2.1.1. Hydrogels
        • 8.2.2.1.1.1. Animal-derived hydrogels
        • 8.2.2.1.1.1.1. Matrigel
        • 8.2.2.1.1.1.2. Collagen
        • 8.2.2.1.1.2. Synthetic hydrogels
        • 8.2.2.1.1.3. Alginate/Agarose
        • 8.2.2.1.2. Inert matrix/Solid scaffolds
        • 8.2.2.1.3. Micropatterned surfaces
      • 8.2.2.2. Scaffold-free technology
        • 8.2.2.2.1. Microplates
        • 8.2.2.2.2. Hanging-drop plates
        • 8.2.2.2.3. Ultra-low binding plates
        • 8.2.2.2.4. Other scaffold-free technologies
    • 8.2.3. PERFUSION CELL CULTURE
  • 8.3. LAB-ON-A-CHIP
  • 8.4. ULTRA-HIGH-THROUGHPUT SCREENING
  • 8.5. BIOINFORMATICS
  • 8.6. LABEL-FREE TECHNOLOGY

9. HIGH-THROUGHPUT SCREENING MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. TARGET IDENTIFICATION AND VALIDATION
  • 9.3. PRIMARY AND SECONDARY SCREENING
  • 9.4. TOXICOLOGY ASSESSMENT
  • 9.5. OTHER APPLICATIONS

10. HIGH-THROUGHPUT SCREENING MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 10.3. ACADEMIC AND GOVERNMENT INSTITUTES
  • 10.4. CONTRACT RESEARCH ORGANIZATIONS (CRO)
  • 10.5. OTHER END USERS

11. HIGH-THROUGHPUT SCREENING MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. US
    • 11.2.2. CANADA
  • 11.3. EUROPE
    • 11.3.1. GERMANY
    • 11.3.2. UK
    • 11.3.3. FRANCE
    • 11.3.4. ITALY
    • 11.3.5. SPAIN
    • 11.3.6. REST OF EUROPE
  • 11.4. ASIA PACIFIC
    • 11.4.1. JAPAN
    • 11.4.2. CHINA
    • 11.4.3. INDIA
    • 11.4.4. REST OF ASIA PACIFIC
  • 11.5. LATIN AMERICA
  • 11.6. MIDDLE EAST AND AFRICA

12. COMPETITIVE LANDSCAPE

  • 12.1. INTRODUCTION
  • 12.2. MARKET LEADERSHIP ANALYSIS
  • 12.3. COMPETITIVE SCENARIO
    • 12.3.1. PRODUCT LAUNCHES AND UPGRADES
    • 12.3.2. PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
    • 12.3.3. EXPANSIONS
    • 12.3.4. ACQUISITIONS
    • 12.3.5. OTHER DEVELOPMENTS

13. COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*

  • 13.1. THERMO FISHER SCIENTIFIC INC.
  • 13.2. AGILENT TECHNOLOGIES, INC.
  • 13.3. DANAHER CORPORATION
  • 13.4. PERKINELMER, INC.
  • 13.5. TECAN GROUP
  • 13.6. AXXAM S.P.A.
  • 13.7. BIO-RAD LABORATORIES
  • 13.8. MERCK GROUP
  • 13.9. HAMILTON COMPANY
  • 13.10. CORNING INCORPORATED
  • 13.11. BIOTEK INSTRUMENTS
  • 13.12. AURORA BIOMED

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. DISCUSSION GUIDE
  • 14.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.4. AVAILABLE CUSTOMIZATIONS
  • 14.5. RELATED REPORTS
  • 14.6. AUTHOR DETAILS
Back to Top